|
|
Volumn 20, Issue 5, 2008, Pages 325-326
|
|
The HiLo Trial: a Multicentre Randomised Trial of High- versus Low-dose Radioiodine, with or without Recombinant Human Thyroid Stimulating Hormone, for Remnant Ablation after Surgery for Differentiated Thyroid Cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IODINE 131;
LIOTHYRONINE;
RADIOACTIVE IODINE;
RECOMBINANT THYROTROPIN;
THYROGLOBULIN;
THYROXINE;
CANCER RISK;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
DRUG DOSE COMPARISON;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG UPTAKE;
EDITORIAL;
EVIDENCE BASED MEDICINE;
HORMONE SUBSTITUTION;
HUMAN;
HYPOTHYROIDISM;
LOW DRUG DOSE;
METHODOLOGY;
MONOTHERAPY;
MULTICENTER STUDY;
OUTCOMES RESEARCH;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RADIOIMMUNOASSAY;
RANDOMIZED CONTROLLED TRIAL;
RISK REDUCTION;
SECOND CANCER;
STANDARDIZATION;
SURVIVAL RATE;
SURVIVAL TIME;
THYROGLOBULIN BLOOD LEVEL;
THYROID CANCER;
THYROIDECTOMY;
TUMOR DIFFERENTIATION;
HORMONES;
HUMANS;
IODINE RADIOISOTOPES;
MULTICENTER STUDIES AS TOPIC;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
THYROID NEOPLASMS;
THYROIDECTOMY;
THYROTROPIN;
|
|
EID: 43049171835
PISSN: 09366555
EISSN: None
Source Type: Journal
DOI: 10.1016/j.clon.2008.03.010 Document Type: Editorial |
|
Times cited : (37)
|
|
References (8)
|
